A Montreal-area dentist is donating money to Type 1 diabetes research — but he wants you to wear blue first. “Let’s use this ...

T1D affects more than 2 million people in the US, and many face barriers to the care, education, medication, and supplies needed to manage their condition. Blue Circle Health aims to inform new ...

Empagliflozin vs placebo was associated with greater reductions in risk for cardiovascular disease among patients with type 1 diabetes. Sodium–glucose cotransporter inhibitors (SGLTis) are ...

People with LADA follow similar T1D practices with insulin, eating, exercise, and blood sugar management. Type 1.5 diabetes is commonly known as LADA, or latent autoimmune diabetes in adults.

TORONTO, May 01, 2025 (GLOBE NEWSWIRE) -- Beginning May 3, 2025, Matt Varey, retired banking executive, Vice Chair of Breakthrough T1D’s International Board, Board Member of Breakthrough T1D ...